SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose 7.0% Beneficial Ownership in Outset Medical Inc.
Beneficial Ownership Report
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting a combined beneficial ownership of 7.0% in Outset Medical Inc. as of December 31, 2024.
Summary
- FMR LLC and Abigail P. Johnson jointly reported beneficial ownership of 3,671,213 shares of Outset Medical Inc. common stock.
- This represents 7.0% of the total outstanding common stock of Outset Medical Inc.
- The filing date for this amendment (Amendment No. 6) is February 11, 2025, with the event date being December 31, 2024.
- FMR LLC holds sole voting power over 3,640,951 shares and sole dispositive power over 3,671,213 shares.
- Abigail P. Johnson, as a Director, Chairman, and CEO of FMR LLC, is deemed to beneficially own the same aggregate amount of shares as FMR LLC.
- The shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
- Select Medical Technology and Devices Portfolio is known to have an interest of 3,300,000 shares, representing 6.3% of the total outstanding common stock as of December 31, 2024.
Sentiment
Score: 5
Explanation: The document is a routine beneficial ownership disclosure (Schedule 13G) and does not contain information that would typically indicate positive or negative sentiment regarding the issuer's performance or outlook. It simply reports a significant institutional stake.
Positives
- FMR LLC, a major investment management firm, maintains a significant 7.0% beneficial ownership stake in Outset Medical Inc., indicating continued institutional interest.
Negatives
- NA
Risks
- The filing explicitly states that the securities were not acquired or held for the purpose of changing or influencing the control of the issuer, which means the reporting parties are not seeking an activist role.
Future Outlook
NA
Management Comments
- "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."
Industry Context
NA
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional ownership, which can be viewed positively as a vote of confidence from a major investor.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC. |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 2023-01-31 | Date of Schedule 13G filing by FMR LLC where Abigail P. Johnson's power of attorney was incorporated by reference. |
| 2024-12-31 | Date of event which requires filing of this statement (reporting period end date). |
| 2025-02-11 | Filing date of the Schedule 13G Amendment No. 6. |
Keywords
Outset Medical Inc, FMR LLC, Abigail P. Johnson, Schedule 13G, beneficial ownership, common stock, institutional ownership, SEC filing, medical technology, healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.